Concepedia

Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial

David J. Werring, Hakim‐Moulay Dehbi, Norin Ahmed, Liz Arram, Jonathan G. Best, Maryam Balogun, Kate Bennett, Ekaterina Bordea, Emilia Caverly, Marisa Chau,

The Lancet · 2024 · 52 citations · 18 references

DOIFull text

Open access

References

18

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Paulus Kirchhof, Stefano Benussi, Dipak Kotecha et al. · EP Europace · 2016 · 6.5K citations · Full text

Interobserver agreement for the assessment of handicap in stroke patients.

John C. van Swieten, Peter J. Koudstaal, Marieke C. Visser et al. · Stroke · 1988 · 6.3K citations · Full text

, , +18

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients

Sam Schulman, Clive Kearon · Journal of Thrombosis and Haemostasis · 2005 · 4.8K citations

, , +13

Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients: communication from the SSC of the ISTH

Scott Kaatz, Alex C. Spyropoulos, Sam Schulman · Journal of Thrombosis and Haemostasis · 2015 · 1.3K citations

, , +14

Early Hemorrhagic Transformation of Brain Infarction: Rate, Predictive Factors, and Influence on Clinical Outcome

Maurizio Paciaroni, Giancarlo Agnelli, Francesco Corea et al. · Stroke · 2008 · 496 citations · Full text